thyroid surgery
Conditions
Interventions
Using neural monitoring,Cervical plexus block group:Take standardized steps for neuromonitoring,after anesthesia induction, in under the guidance of ultrasound with 0.375% pp paid 10 ml implement bila
Using neural monitoring,lidocaine group:Take standardized steps for neuromonitoring,lidocaine 1.5mg/kg was pumped intravenously before induction of anesthesia, followed by 1.5mg/kg/h intravenous infus
Using neural monitoring,saline control group:Take standardized steps for neuromonitoring,the intravenous infusion of normal saline was the same as that of lidocaine group and the use of normal saline
No nerve monitoring,Cervical plexus block group:No nerve monitoring ,after anesthesia induction, in under the guidance of ultrasound with 0.375% pp paid 10 ml implement bilateral neck shallow plexus n
No nerve monitoring,lidocaine group:No nerve monitoring,lidocaine 1.5mg/kg was pumped intravenously before induction of anesthesia, followed by 1.5mg/kg/h intravenous infusion until the end of surgery
No nerve monitoring,saline control group:No nerve monitoring,the intravenous infusion of normal saline was the same as that of lidocaine group and the use of normal saline was the same as that of cerv
Sponsors
The Affiliated Huaian Hospital of Xuzhou Medical University, Huai'an Second Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients undergoing thyroidectomy under general anesthesia 2.ASA ?-?; 3.Aged 18-65 years.
Exclusion criteria
Exclusion criteria: 1. Patients who do not sign informed consent; 2. Patients with heart, brain, lung, liver, kidney and other major organ diseases; 3. Patients with hypertension or hyperthyroidism; 4. The scope of operation was changed, thyroid resection or cervical lymph node dissection was not performed; 5. Patients with coagulation disorders or blood system diseases; 6. Allergic to lidocaine and other experimental drugs or adverse drug reactions, such as allergic reaction, poisoning reaction; 7. pregnant and lactating women; 8. surgical site or systemic infection; 9. Difficult airway during induction of anesthesia, and conventional intubation should be changed; 10. Patients refused to continue the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QoR-40;SAS;SDS;PSQI;Nerve monitoring EMG signal parameters; | — |
Countries
China
Contacts
Public ContactChenglan Xie
The Affiliated Huaian Hospital of Xuzhou Medical University, Huai'an Second Hospital
Outcome results
None listed